Elanco Animal Health Incorporated fell 1.55% in after-hours trading. The company reported beating Q2 revenue estimates and raising FY guidance, which is typically a bullish indicator. However, the stock's decline suggests that investors may be reacting to other factors, such as broader market sentiment or concerns about future performance despite the positive earnings report.
Comments
No comments yet